Global Neurovascular Devices Market Overview And Scope:
Global Neurovascular Devices Market Size was estimated at USD 184.92 million in 2022 and is projected to reach USD 255.78 million by 2028, exhibiting a CAGR of 5.55% during the forecast period.
The Global Neurovascular Devices Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Neurovascular Devices utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Stryker Corporation, Johnson and Johnson, Medtronic, Terumo, Penumbra, Microport Scientific Corporation, Abbott Vascular, W. L. Gore and Associates
Global Neurovascular Devices Market Segmentation
By Type, Neurovascular Devices market has been segmented into:Aneurysm Coiling and Embolization Devices
Cerebral Balloon Angioplasty and Stenting Systems
Support Devices
Neurothrombectomy Devices
By Application, Neurovascular Devices market has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Units
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Neurovascular Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Neurovascular Devices market.
Top Key Players Covered in Neurovascular Devices market are:
Stryker Corporation
Johnson and Johnson
Medtronic
Terumo
Penumbra
Microport Scientific Corporation
Abbott Vascular
W. L. Gore and Associates
Objective to buy this Report:
1. Neurovascular Devices analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Neurovascular Devices market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Neurovascular Devices Market by Type
5.1 Neurovascular Devices Market Overview Snapshot and Growth Engine
5.2 Neurovascular Devices Market Overview
5.3 Aneurysm Coiling and Embolization Devices
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Aneurysm Coiling and Embolization Devices: Geographic Segmentation
5.4 Cerebral Balloon Angioplasty and Stenting Systems
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Cerebral Balloon Angioplasty and Stenting Systems: Geographic Segmentation
5.5 Support Devices
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Support Devices: Geographic Segmentation
5.6 Neurothrombectomy Devices
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Neurothrombectomy Devices: Geographic Segmentation
Chapter 6: Neurovascular Devices Market by Application
6.1 Neurovascular Devices Market Overview Snapshot and Growth Engine
6.2 Neurovascular Devices Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinics: Geographic Segmentation
6.5 Ambulatory Surgical Units
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Ambulatory Surgical Units: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Neurovascular Devices Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Neurovascular Devices Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Neurovascular Devices Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 STRYKER CORPORATION
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 JOHNSON AND JOHNSON
7.4 MEDTRONIC
7.5 TERUMO
7.6 PENUMBRA
7.7 MICROPORT SCIENTIFIC CORPORATION
7.8 ABBOTT VASCULAR
7.9 W. L. GORE AND ASSOCIATES
Chapter 8: Global Neurovascular Devices Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Aneurysm Coiling and Embolization Devices
8.2.2 Cerebral Balloon Angioplasty and Stenting Systems
8.2.3 Support Devices
8.2.4 Neurothrombectomy Devices
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Ambulatory Surgical Units
Chapter 9: North America Neurovascular Devices Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Aneurysm Coiling and Embolization Devices
9.4.2 Cerebral Balloon Angioplasty and Stenting Systems
9.4.3 Support Devices
9.4.4 Neurothrombectomy Devices
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Clinics
9.5.3 Ambulatory Surgical Units
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Neurovascular Devices Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Aneurysm Coiling and Embolization Devices
10.4.2 Cerebral Balloon Angioplasty and Stenting Systems
10.4.3 Support Devices
10.4.4 Neurothrombectomy Devices
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Clinics
10.5.3 Ambulatory Surgical Units
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Neurovascular Devices Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Aneurysm Coiling and Embolization Devices
11.4.2 Cerebral Balloon Angioplasty and Stenting Systems
11.4.3 Support Devices
11.4.4 Neurothrombectomy Devices
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Clinics
11.5.3 Ambulatory Surgical Units
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Neurovascular Devices Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Aneurysm Coiling and Embolization Devices
12.4.2 Cerebral Balloon Angioplasty and Stenting Systems
12.4.3 Support Devices
12.4.4 Neurothrombectomy Devices
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Clinics
12.5.3 Ambulatory Surgical Units
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Neurovascular Devices Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Aneurysm Coiling and Embolization Devices
13.4.2 Cerebral Balloon Angioplasty and Stenting Systems
13.4.3 Support Devices
13.4.4 Neurothrombectomy Devices
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Clinics
13.5.3 Ambulatory Surgical Units
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Neurovascular Devices Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Aneurysm Coiling and Embolization Devices
14.4.2 Cerebral Balloon Angioplasty and Stenting Systems
14.4.3 Support Devices
14.4.4 Neurothrombectomy Devices
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Clinics
14.5.3 Ambulatory Surgical Units
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Neurovascular Devices Scope:
|
Report Data
|
Neurovascular Devices Market
|
|
Neurovascular Devices Market Size in 2025
|
USD XX million
|
|
Neurovascular Devices CAGR 2025 - 2032
|
XX%
|
|
Neurovascular Devices Base Year
|
2024
|
|
Neurovascular Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Stryker Corporation, Johnson and Johnson, Medtronic, Terumo, Penumbra, Microport Scientific Corporation, Abbott Vascular, W. L. Gore and Associates.
|
|
Key Segments
|
By Type
Aneurysm Coiling and Embolization Devices
Cerebral Balloon Angioplasty and Stenting Systems
Support Devices
Neurothrombectomy Devices
By Applications
Hospitals
Clinics
Ambulatory Surgical Units
|
